We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current XENE market cap is 2.26B. The company's latest EPS is USD -1.9095 and P/E is -17.78.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 536k | 132k | 0 | 0 | 0 |
| Operating Income | -30.32M | -38.13M | -43.33M | -47.37M | -53.67M |
| Net Income | -31.16M | -37.15M | -36.96M | -41.73M | -47.46M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 6.83M | 32.17M | 18.44M | 9.43M |
| Operating Income | -38.02M | -42.82M | -31.3M | -78.99M | -129.14M |
| Net Income | -34.5M | -41.6M | -28.01M | -77.09M | -124.94M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 807.38M | 775.81M | 754.15M | 719.87M | 684.9M |
| Total Liabilities | 21.59M | 22.69M | 32.65M | 32.92M | 38.44M |
| Total Equity | 785.79M | 753.12M | 721.5M | 686.94M | 646.46M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 122.43M | 147.7M | 189.19M | 572.01M | 754.15M |
| Total Liabilities | 19.13M | 55.72M | 17.83M | 21.97M | 32.65M |
| Total Equity | 103.3M | 91.98M | 171.36M | 550.03M | 721.5M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -35.3M | -65.7M | -98.43M | -34.41M | -67.63M |
| Investing | -47.57M | -281.67M | -296M | 46.62M | 74.52M |
| Financing | 277.77M | 278.47M | 278.47M | N/A | N/A |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -34.72M | -4.63M | -48.12M | -69.5M | -98.43M |
| Investing | -28.99M | -66.29M | -16.82M | -246.77M | -296M |
| Financing | 111.59M | 27.52M | 85.8M | 447.54M | 278.47M |
| Market Cap | 2.26B |
| Price to Earnings Ratio | -17.78 |
| Price to Sales Ratio | 235.44 |
| Price to Cash Ratio | 38.8 |
| Price to Book Ratio | 3.08 |
| Dividend Yield | - |
| Shares Outstanding | 65.43M |
| Average Volume (1 week) | 1.19M |
| Average Volume (1 Month) | 807.66k |
| 52 Week Change | -2.1% |
| 52 Week High | 43.75 |
| 52 Week Low | 27.985 |
| Spread (Intraday) | 0.04 (0.12%) |
| Company Name | Xenon Pharmaceuticals Inc |
| Address |
200 - 3650 gilmore way burnaby, british columbia V5G 4W8 |
| Website | https://www.xenon-pharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
